A SIMPLE
AND
METHOD
FOR
SENSITIVE TAURINE
PAPER Kazuaki
FLUOROMETRIC USING
ASSAY
HIGH-VOLTAGE
ELECTROPHORESIS
YOSHIKAWA
and Kinya KURIYAMA
Department of Pharmacology, Kyoto Prefectural University of Medicine, Kamikyo-ku, Kyoto 602, Japan Accepted July 6, 1976
Abstract-A simple and sensitive fluorometric assay method for taurine (2-amino ethanesulfonic acid) has been developed. For the separation of taurine, high voltage paper electrophoresis subsequent to column chromatographic procedures was employed. Fluorescent product of taurine was yielded by spraying fluorescamine (4-phenylspiro [furan-2(3H), 1'-phthalan]-3, 3'-dione) and borate buffer on the paper, and the fluo rescence was assayed spectro-fluorometrically after eluting with 50% ethanol. The linear relationship between the concentration of taurine and fluorescence developed was achieved over the concentration ranges of 0.5-10 nmoles, and the recoveries obtained were 90-100%. The specificity of this method for taurine was satisfactory and structural analogues involved in the metabolic pathway of taurine did not interfere with the assay. Examples for tissue levels of taurine in various organs of the rat as de termined by this new method are also presented.
Although taurine is known to be present in almost all organs of animals, physiological or functional role of this compound is not fully understood.
For the assay of taurine,
ninhydrin or o-phthaldehyde reaction (1) has been usually employed after separating this compound by column (2), thin layer (3), paper chromatographic voltage paper electrophoresis (4).
procedures, and/or high
These colorimetric methods, however, lack the sensitivity
capable of determining taurine contents in a small amount
of tissue.
Recently, more
sensitive radiometric (5), fluorometric (6) or enzymatic assay (7) methods have been reported. These methods, however, are troublesome and have disadvantages in terms of rapidity, simplicity and difficulties in selecting the assay conditions.
High-voltage electrophoresis,
used in many laboratories today, is thought to have the advantages of rapidity and efficiency in isolating amino acids.
On the other hand, it is known that fluorescamine reacts with
primary amines and develops fluorescence. This reaction has been reported to retain simplicity as well as rapidity (8, 9). Described herein is a sensitive and rapid assay method for taurine using high-voltage paper electrophoresis and fluorescamine as a fluorescent probe. MATERIALS AND METHODS Column chromatography Ion exchange column (cation exchanger; Dowex 50W x 2, 200-400 mesh, H+ form, 0.3 x 10 cm) was prepared according to the procedure described by Iversen and Kravitz (10).
The column was eluted with distilled water, the initial 0.4 ml of eluent was discarded and the following 0.8 ml was collected as a taurine fraction. to dryness in a dryer chamber at 100'C.
This fraction was then evaporated
The residue was redissolved in an adequate volume
of water and taurine content in the solution was adjusted to 0.5-10 nmoles of taurine per 10 t11(see `Results'). High-voltage paper electrophoresis High-voltage
paper electrophoretic
cooling solvent (Toyo Cool X) was used.
apparatus
(Toyo HPE-406) equipped with the
The paper (Toyo No. 51A, nearly equivalent to
Whatmann No. 1, 2 x 40 cm, weight 85 g/m', thickness 0.16 mm, smooth surface) was used without any pre-treatment.
The 10 /al of sample was applied at the point 17 cm from the
anodal end with a micropipette.
The conditions for electrophoresis based on the method
of Mabry and Todd (11) were as follows; Buffer solution used: formate: acetate: H2O=6: 24:170 (pH 2.0), Potential gradient: 90 V/cm, Duration
of electrophoresis:
25 minutes.
After electrophoresis, the papers were dryed with a dryer (hanging type) and the next process was the development of the fluorescence. Fluorescence development The papers were set vertically and the 0.015% fluorescamine (Fluram, Hoffmann-La Roche Co.) in acetone (W/V) was sprayed on manually. buffer (pH 9.5) was applied by spraying. dryed with a dryer. 0
A few minutes later 0.5 M borate
The papers were kept for 10 minutes and then
After detecting the fluorescent spots under the U.V. lamp (wave length:
3650 A), the taurine spot was cut out and eluted for 10 minutes or longer with 3 ml of 50 ethanol
in test tubes.
excitation Preparation
capitated,
of the eluent was measured
rats weighing
and immediately at -80°C
150-200
g or male ddY mice weighing
each organ was removed
and frozen.
in a deep freezer until each assay.
10 Vol. of 75'/0' ethanol
type, 1 ml in a total volume).
dryness
in vacuo and the residue was dissolved
and mixing with 0.2 ml of chloroform, al of the upper
aqueous
at
the tube was centrifuged applied
with
into the microtube
was then evaporated
in 0.1 nil of distilled
was then
g were de
These frozen tissues were
was transferred
The homogenate
phase
25-30
Each tissue was homogenized
and 0.2 nil of the homogenate
(conical
Seventy
spectrofluorometrically
wave lengths of 390 and 490 nm, respectively.
of tissue extracts
Male Wistar
stocked
Fluorescence
and emission
water.
to a near
After adding
at 3,000 r.p.m. for 10 minutes. to the
column
as described
previously. The recovery
of taurine was estimated
by using an internal
4-10 nmoles taurine were added to the known amount to the extraction
procedures
as described
above.
m mole) was also added to each homogenate completing
extraction
extract
was transferred
(12).
The radioactivity
with 50'./ ethanol into a counting
standard
of tissue homogenate Trace amount
for estimating
from the fluorescent vial containing
in these vials was determined
method,
before subjection
of "C-taurine
the recovery spot,
(1-5 mCi;
of taurine.
After
1 ml of the fluorescent
10 ml of Bray's scintillation in a Packard
in which
cocktail
3390 liquid scintillation
spectrometer. RESULTS A linear relationship rescence was obtained ranges
between
as shown in Fig. 1.
of 0.5-10 nmoles.
standard
from fluorescent
the column
compounds could
(i.e. primary
amines
In this column
such as amino
in the taurine
fraction.
To exclude
of duplicate measurements. Ten standard solution with varying taurine
was
applied
to the paper and the fluorescence was measured following electrophoresis and fluorescamine treatment (see "Methods"). Fluorescence units.
intensity
acids,
Only
from actual
from the
blank areas on the The extraction
is given in arbitrary
pH.
The elution
was
pattern
procedure,
fluorescamine
reactive
polyamines
and biogenic
amines)
O-phosphoethanolamine,
with a similar migrating
FIG. 1. Fluorescence intensity at varying con centrations of taurine. A typical example is shown. Each point represents the
of
of fluo
within 5 minutes and the stability of fluorescence
in Fig. 2.
reactive compounds
concentrations
by the extrapolation
for over several hours at neutral-alkali
is shown
(11), was eluted closely to taurine.
average tl of
value calculated
well with the value obtained
spots was completed
not be eluted
fluorescamine
and the intensity
usually the former value was used as an assay blank.
found to be maintained from
of taurine
The linearity was achieved over the concentration
Since the blank
curve corresponded
same chromatogram,
the concentration
rate in electrophoretic
this compound
from
one of the procedures
the taurine
fraction,
FiG. 2. Elution pattern of taurine in column procedures. Taurine and 0-phosphoetha nolamine, both 50 nmoles in 10 Id, were applied to the column and every 0.1 ml of the fraction was collected. To each frac tion, 0.2 ml of 0.2 M borate buffer (pH 9.0) and 0.1 ml of 0.015 % (W/V) fluorescamine in acetone were added and mixed. After adjusting the final volume to 3 ml with distilled water, the fluorescence was mea sured. "C-taurine was also applied for identifying the taurine fraction in the pre sence of taurine and 0-phosphoethanol amine. The intensity of fluorescence is given in arbitrary units. The horizontal solid bar in the figure indicates the taurine fraction used (0.8 ml).
FIG. 3. High voltage paper electiophoretic profiles of taurine, its structural anal ogues, and profile of extract from mouse cerebral cortex. Standard solutions, containing 5 nmoles of each compound in 10,al, were applied and treated in the same manner as described in Methods. The fluorescence was measured directly on the paper with a fluorodensitometer (Shimazu CS-910) at excitation and emission wave lengths of 365 and 450 nm, respectively. The shaded arrow indicates the origin of sample application.
FIG. 4.
Relationship
Mouse cerebral were transferred
between
the
amount
of tissue
used
genate which corresponded to 0.5, 1, 2, 4 mg of tissues. average of duplicate measurements.
the column chromatographic
the
taurine
content.
procedure
Each point represents
the
procedures were applied and the separation of O-phosphoe
thanolamine from taurine was achieved (Fig. 2). chromatographic
and
cortex was homogenized and various amounts of the homogenate respectively to microtubes so that each tube contained the homo
was approximately
The recovery of taurine during this column 100%.
To examine the specificity for
taurine, structural analogues involved in the metabolic pathway of taurine and possibly to be eluted out from the column (hypotaurine, cysteic acid, cysteinesulfinic acid) were also tested with the extract from mouse cerebral cortex (Fig. 3).
The migration pattern of the extract
showed a single peak identical with that of authentic taurine and no overlapping of peaks of the structural analogues and that of taurine was observed, indicating that the taurine fraction was not contaminated by these compounds.
The linear relationship between the
amount of cerebral cortical tissues used and the amount of taurine obtained is shown in Fig. 4. The concentration of taurine in mouse cerebral cortex was 11 amoles/g wet weight,
TABLL 1.
Taurine
Each
value
three
separate
concentration
represents
the
in various
mean
_ __ S.D.
organs
obtained
of rat
from
determinations.
as calculated from the curve shown in Fig. 4. Tissue levels of taurine in various organs of the rat measured by this method are shown in Table 1. The values obtained were essentially in agreement with those in previous reports (12, 13, 14, 15, 16); the pituitary gland had the highest level of taurine, and relatively high levels in heart, spleen and adrenal gland were also noted among the various organs tested. The recovery of tissue taurine through the entire assay procedures was 90-100 % as determined by either an internal standard "Methods") .
procedure
or the recovery of added '4C-taurine (see
DISCUSSION There is a considerable volume of literature on the fluorescamine reaction in the aqueous phase (9, 17), but quantitative fluorometric procedures using paper electrophoresis have not been documented. In our preliminary experiments, it was found that the fluorescence of taurine yielded by fluorescamine was 2-3 times higher than fluorescence of other amino acids and excellent linearity was retained.
On the contrary, color development of taurine
by ninhydrin reaction was extremely poor as compared with other amino acids (18). For the assay of taurine using electrophoresis,
there is no doubt that the use of fluo
rescamine as a fluorescent probe is superior to that of ninhydrin. disadvantages of this method which should also be noted;
There are, however,
1) Absolute fluorescence intensity
is variable, so that standards are always necessary in each group of assays when fluorescence is developed.
Usually, standards with two different concentrations
the paper before electrophoresis were satisfactory for routine assays.
of taurine applied to 2) Although it is a
somewhat time consuming processes, the use of column procedures before applying electro phoresis is advisable to exclude other interfering substances including O-phosphoethanol amine and also to obtain constant migration patterns.
This method
is also considered
useful to separate
compounds,
since no interference
was counted
directly in a liquid scincillation
Acknowledgernent: and 048254 (1975))
was detected
when the radioactivity
taurine
or related
of fluorescent
spots
system using Bray's Solution (12).
This work was supported
from the Ministry
the radioactive
of Education,
in part by research
grants (Nos. 087119
Japan.
REFERENCES 1) 2) 3) 4)
GAITONDE,M.K. AND SHORT,R.A.: Analyst 96, 274 (1971) HUXTABLE,R. AND BRESSLER,R.: Life Sci. 14, 1353 (1974) GUIDOTTI,A., BADIANi,G. ANDPEPEU, G.: J. Neurocheni. 19, 431 (1972) IWATA,H., BABA,A. ANDYONEDA,Y.: Tailrine, Edited by HUXTABLE,R. AND BARBEAU,A., p. 85, Raven Press, New York (1976) 5) KARLSSON,A., FONNUM, F., MALTHE-SORESSEN, D. AND STORM-MATHISEN,J.: Biochem. Pharmacol. 23, 3053 (1974) 6) ORR, H.T., COHEN, A.I. ANDLOWRY,O.H.: J. Nenrochem. 26, 609 (1976) 7) LoNIBARDINI, J.B.: J. Pharmacol. exp. Thcr. 193, 301 (1975) 8) WEIGELE,M., DE BERNARDO,S.L., TENGI, J.P. ANDLFIMGRUBER,W.: J. Aln. Chem. Soc. 94, 5927 (1972) 9) UDENFRIEND,S., STEIN, S., B(5HLEN,P., DAIRMAN,W., LEIMGRUBER,W. AND WEIGELE,M.: Science 178, 871 (1972) 10) IVERSEN,L.L. AND KRAVITZ,E.A.: J. Neurochem. 15, 609 (1968) 11) MABRY,C.C. AND TODD, W.R.: J. Lab. clin. 11.1ed.61, 146 (1963) 12) BRAY,G.A.: Analyt. Biochem. 1, 279 (1960) 13) AWAPARA,J.: J. biol. Chem. 218, 571 (1956) 14) GARVIN,J.E.: Archs Biochem. Biophys. 91, 219 (1960) 15) NAKAGAWA,K. AND KURIYAMA,K.: Japan. J. Pharmacol . 25, 737 (1975) 16) CRABAI,F., SITZIA,A. ANDPEPEU, G.: J. Neurochem. 23, 1091 (1974) 17) UDENFRIEND, S., STEIN, S., BOHL.EN,P. ANDDAIRMAN,W.: Chemistry and Biology of Peptides, Edited by MEIENHOFER, J., p. 655, Ann Arbor Science (1972) 18) TSUKADA,Y. AND NAGATA,Y.: Seikagaku 51, 33 (1961) (in Japanese)